1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Bifidobacterium longum subsp. infantis M-63 has redefined the global probiotic landscape by aligning scientific breakthroughs with evolving consumer and industry needs. As this market experiences robust transformation driven by demand for targeted, evidence-based products, industry leaders are navigating opportunities and risks with renewed agility.
Market Snapshot: The Rise of Bifidobacterium longum subsp. infantis M-63
The primary keyword, Bifidobacterium longum subsp. infantis M-63, anchors a market propelled by innovation in microbial science and consumer preferences for health optimization. The sector has seen significant growth, underpinned by expanding applications beyond infant nutrition into adult health, functional foods, supplements, and pharmaceutical adjuncts. Market participants benefit from technological advancements such as precision fermentation, dynamic regulatory frameworks, and digital health integration, all fostering differentiation and strategic expansion.
Scope & Segmentation Across the Probiotic Value Chain
This report provides a comprehensive outlook on the Bifidobacterium longum subsp. infantis M-63 market, organized by application areas, forms, end-user segments, regional presence, and distribution strategies.
- Application Areas: Animal feed, dietary supplements, functional foods, infant formula, and pharmaceutical uses.
- Forms: Enteric-coated capsules, non-enteric capsules, liquid, powder, and tablet formulations.
- End Users: Adults, children, elderly, and infants, each with unique needs for gut health and immune function.
- Distribution Channels: Direct sales, digital channels, hospital procurement, and retail pharmacies.
- Regional Focus: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering United Kingdom, Germany, France, Russia, Italy, Spain, several Gulf and African states), and Asia-Pacific (China, India, Japan, Australia, South Korea, and others).
- Key Companies Featured: Morinaga Milk Industry Co., Ltd., Danone S.A., Yakult Honsha Co., Ltd., Nestlé S.A., Chr. Hansen A/S, DuPont de Nemours, Inc., Kerry Group plc, Lallemand Inc., BioGaia AB, Probi AB.
- Technologies Highlighted: Microbiome analytics, artificial intelligence, proprietary microencapsulation, modular production platforms, and precision fermentation.
Key Takeaways for Senior Decision Makers
- The versatility of M-63 is extending usage from pediatric nutrition to adult dietary supplements, functional beverages, and adjunctive therapies.
- Emerging consumer demand is focused on products offering clinically validated, targeted benefits and personalized formulations.
- Advances in microbial cultivation and digital health are enabling real-time monitoring, improved product recommendations, and precise dosing.
- Regulatory adaptation is shaping clear pathways for labeling, compliance, and cross-border approvals, strengthening consumer trust.
- Strategic alliances and co-innovation, from global nutrition companies to biotech startups, are catalyzing rapid scale-up and modular customization for diverse clinical and wellness segments.
- Supply chain design is shifting with tariff adjustments, prompting investments in domestic and nearshore manufacturing to enhance operational resilience and agility.
Tariff Impact on Probiotic Ingredient Supply and Costs
Recent United States tariff changes have introduced complexities for supply chains reliant on imported fermentation media, packaging, and specialty ingredients. Manufacturers are reassessing sourcing strategies—evaluating domestic production and partnerships within North America—to protect margins and guarantee quality. Such shifts may spur further innovation in logistics, strengthen local manufacturing ecosystems, and shape future pricing and contractual relationships across the value chain.
Methodology & Data Sources
The research methodology integrates primary interviews with stakeholders such as formulation scientists, regulatory experts, clinicians, and procurement leaders. Complemented by on-site facility visits and secondary reviews of scientific literature, regulatory filings, and patent data, stringent triangulation ensures accuracy and relevance for each market segment.
Why This Report Matters: Decision Support for Probiotic Expansion
- Empowers business leaders with validated trend analysis, actionable segmentation, and technology roadmaps for targeted investment.
- Supports operational strategy with in-depth supply chain, regulatory, and partnership insights, enabling robust risk mitigation and market entry optimization.
- Equips R&D, marketing, and C-suite teams with intelligence to translate scientific advancement into sustainable competitive advantage.
Conclusion
Bifidobacterium longum subsp. infantis M-63 stands at the intersection of science, technology, and consumer health. Organizations combining clinical rigor with market adaptability will unlock comprehensive value and shape the future of probiotic innovation.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Innovative infant formula fortification with B. Infantis M-63 for gut health
5.2. Clinical studies highlighting B. Infantis M-63 efficacy in neonatal immune development
5.3. Consumer demand shift towards probiotic strains with documented genomic stability like M-63
5.4. Partnerships between probiotic manufacturers and pediatric healthcare providers for M-63 applications
5.5. Regulatory approvals and novel submission pathways for infant-specific probiotic strains such as M-63
5.6. Advances in microencapsulation technologies to improve shelf stability of B. Infantis M-63
5.7. Rise of personalized nutrition platforms recommending B. Infantis M-63 based on individual microbiome profiles
5.2. Clinical studies highlighting B. Infantis M-63 efficacy in neonatal immune development
5.3. Consumer demand shift towards probiotic strains with documented genomic stability like M-63
5.4. Partnerships between probiotic manufacturers and pediatric healthcare providers for M-63 applications
5.5. Regulatory approvals and novel submission pathways for infant-specific probiotic strains such as M-63
5.6. Advances in microencapsulation technologies to improve shelf stability of B. Infantis M-63
5.7. Rise of personalized nutrition platforms recommending B. Infantis M-63 based on individual microbiome profiles
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Application
8.1. Introduction
8.2. Animal Feed
8.2.1. Aquaculture Feed
8.2.2. Livestock Feed
8.2.3. Pet Food
8.3. Dietary Supplements
8.3.1. Adult Supplements
8.3.2. Elderly Supplements
8.3.3. Infant Supplements
8.4. Functional Foods
8.4.1. Beverages
8.4.2. Dairy Products
8.4.3. Snack Bars
8.5. Infant Formula
8.5.1. Cow Milk-Based
8.5.2. Hypoallergenic
8.5.3. Soy-Based
8.6. Pharmaceuticals
8.6.1. Adjunctive Therapies
8.6.2. Probiotic Therapeutics
8.2. Animal Feed
8.2.1. Aquaculture Feed
8.2.2. Livestock Feed
8.2.3. Pet Food
8.3. Dietary Supplements
8.3.1. Adult Supplements
8.3.2. Elderly Supplements
8.3.3. Infant Supplements
8.4. Functional Foods
8.4.1. Beverages
8.4.2. Dairy Products
8.4.3. Snack Bars
8.5. Infant Formula
8.5.1. Cow Milk-Based
8.5.2. Hypoallergenic
8.5.3. Soy-Based
8.6. Pharmaceuticals
8.6.1. Adjunctive Therapies
8.6.2. Probiotic Therapeutics
9. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Form
9.1. Introduction
9.2. Capsule
9.2.1. Enteric-Coated
9.2.2. Non-Enteric
9.3. Liquid
9.4. Powder
9.5. Tablet
9.2. Capsule
9.2.1. Enteric-Coated
9.2.2. Non-Enteric
9.3. Liquid
9.4. Powder
9.5. Tablet
10. Bifidobacterium Longum Subsp. Infantis M-63 Market, by End User
10.1. Introduction
10.2. Adults
10.3. Children
10.4. Elderly
10.5. Infants
10.2. Adults
10.3. Children
10.4. Elderly
10.5. Infants
11. Bifidobacterium Longum Subsp. Infantis M-63 Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.2.1. Direct Marketing
11.2.2. Healthcare Practitioner Channel
11.3. E-Commerce
11.3.1. Direct-To-Consumer
11.3.2. Third-Party Platform
11.4. Hospitals
11.4.1. Private Hospital
11.4.2. Public Hospital
11.5. Retail Pharmacies
11.5.1. Chain Pharmacy
11.5.2. Independent Pharmacy
11.2. Direct Sales
11.2.1. Direct Marketing
11.2.2. Healthcare Practitioner Channel
11.3. E-Commerce
11.3.1. Direct-To-Consumer
11.3.2. Third-Party Platform
11.4. Hospitals
11.4.1. Private Hospital
11.4.2. Public Hospital
11.5. Retail Pharmacies
11.5.1. Chain Pharmacy
11.5.2. Independent Pharmacy
12. Americas Bifidobacterium Longum Subsp. Infantis M-63 Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bifidobacterium Longum Subsp. Infantis M-63 Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bifidobacterium Longum Subsp. Infantis M-63 Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Morinaga Milk Industry Co., Ltd.
15.3.2. Danone S.A.
15.3.3. Yakult Honsha Co., Ltd.
15.3.4. Nestlé S.A.
15.3.5. Chr. Hansen a/S
15.3.6. DuPont de Nemours, Inc.
15.3.7. Kerry Group plc
15.3.8. Lallemand Inc.
15.3.9. BioGaia AB
15.3.10. Probi AB
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Morinaga Milk Industry Co., Ltd.
15.3.2. Danone S.A.
15.3.3. Yakult Honsha Co., Ltd.
15.3.4. Nestlé S.A.
15.3.5. Chr. Hansen a/S
15.3.6. DuPont de Nemours, Inc.
15.3.7. Kerry Group plc
15.3.8. Lallemand Inc.
15.3.9. BioGaia AB
15.3.10. Probi AB
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHAI
FIGURE 24. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHSTATISTICS
FIGURE 25. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHCONTACTS
FIGURE 26. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHAI
FIGURE 24. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHSTATISTICS
FIGURE 25. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHCONTACTS
FIGURE 26. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT MARKETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT MARKETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HEALTHCARE PRACTITIONER CHANNEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HEALTHCARE PRACTITIONER CHANNEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 179. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 182. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 183. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 184. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 185. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 186. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 187. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 188. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 189. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 190. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 191. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 192. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 193. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 194. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 195. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 200. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 201. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 202. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 203. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 210. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 211. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY AQUACULTURE FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIVESTOCK FEED, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PET FOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULT SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT SUPPLEMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY BEVERAGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DAIRY PRODUCTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SNACK BARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COW MILK-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HYPOALLERGENIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY SOY-BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADJUNCTIVE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PROBIOTIC THERAPEUTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ENTERIC-COATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY NON-ENTERIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ADULTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHILDREN, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ELDERLY, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT MARKETING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT MARKETING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HEALTHCARE PRACTITIONER CHANNEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HEALTHCARE PRACTITIONER CHANNEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY THIRD-PARTY PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 165. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 166. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 167. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 179. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 180. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 181. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 182. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 183. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 184. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 185. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 186. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 187. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 188. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 189. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 190. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 191. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 192. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 193. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 194. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 195. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 196. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 197. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 200. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 201. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 202. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 203. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 206. CANADA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 207. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 208. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 209. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 210. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 211. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 212. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 213. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 214. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 215. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 216. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 217. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 218. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 219. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 220. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 221. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 222. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 223. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 228. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 229. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 230. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 231. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 232. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 233. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 234. MEXICO BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 237. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 238. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 239. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 240. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 241. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 242. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 243. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 244. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 245. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2018-2024 (USD MILLION)
TABLE 246. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY PHARMACEUTICALS, 2025-2030 (USD MILLION)
TABLE 247. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2018-2024 (USD MILLION)
TABLE 248. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FORM, 2025-2030 (USD MILLION)
TABLE 249. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2018-2024 (USD MILLION)
TABLE 250. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY CAPSULE, 2025-2030 (USD MILLION)
TABLE 251. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2018-2024 (USD MILLION)
TABLE 256. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIRECT SALES, 2025-2030 (USD MILLION)
TABLE 257. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2018-2024 (USD MILLION)
TABLE 258. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY E-COMMERCE, 2025-2030 (USD MILLION)
TABLE 259. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 262. BRAZIL BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 263. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 264. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 265. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2018-2024 (USD MILLION)
TABLE 266. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY ANIMAL FEED, 2025-2030 (USD MILLION)
TABLE 267. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2018-2024 (USD MILLION)
TABLE 268. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY DIETARY SUPPLEMENTS, 2025-2030 (USD MILLION)
TABLE 269. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2018-2024 (USD MILLION)
TABLE 270. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY FUNCTIONAL FOODS, 2025-2030 (USD MILLION)
TABLE 271. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2018-2024 (USD MILLION)
TABLE 272. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY INFANT FORMULA, 2025-2030 (USD MILLION)
TABLE 273. ARGENTINA BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS M-63 MARKET SIZE, BY
Samples
LOADING...
Companies Mentioned
The companies profiled in this Bifidobacterium Longum Subsp. Infantis M-63 market report include:- Morinaga Milk Industry Co., Ltd.
- Danone S.A.
- Yakult Honsha Co., Ltd.
- Nestlé S.A.
- Chr. Hansen A/S
- DuPont de Nemours, Inc.
- Kerry Group plc
- Lallemand Inc.
- BioGaia AB
- Probi AB
